BeStock  
Stocks › Biotechnology › CGEM

Cullinan Therapeutics CGEM

US equityMarket cap rank #3511Biotechnology
$8.89 −$0.18 (-1.98%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $8.96 +0.79%
Open$8.84
Prev close$9.07
Day range$8.80 – $9.46
Volume1.01M
Market cap$577.15M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership111.0%-3.06 pts vs. prior quarter
Institutions holding222-4 vs. prior quarter
Insider trades (recent)17 buys / 33 sellsNet selling
Short interest12.32% of floatDays to cover 13.3 · as of 30 Oct 2026
Short-sale volume share23.9%5-day average of daily volume

Short-sale volume as % of daily volume

13%21%30%38%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$1.17M (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$804.1KSuper−$366.7KBig−$105.5KMid−$1.5MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 51.7% of shares outstanding.

Largest holders

  • MPM BioImpact LLC14.99%
  • Lynx1 Capital Management LP13.81%
  • BVF Partners L.P.8.86%
  • BlackRock8.19%
  • T. Rowe Price Group, Inc.5.89%
  • Kynam Capital Management, LP4.80%
  • Vanguard Capital Management, LLC4.07%
  • State Street Global Advisors4.01%

By investor type

  • Mutual Fund53.98%
  • Hedge Fund26.58%
  • VC/PE Fund24.01%
  • Public Company3.87%
  • Individual/Insider1.04%
  • Family Office/Trust0.92%
  • Insurance Company0.71%
  • Private Company0.69%

Reported short interest has fallen from 16.45% to 12.32% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Fisher Investments Mutual Fund 2026/Q3 +764,963 1.2%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +144,015 0.4%
Raymond James Financial, Inc. Public Company 2026/Q3 +98,240 0.2%
FMR Mutual Fund 2026/Q3 +96,336 0.5%
BlackRock Mutual Fund 2026/Q3 +86,547 8.2%
Ellsworth Advisors, LLC Mutual Fund 2026/Q3 +74,856 0.1%
MPM BioImpact LLC VC/PE Fund 2026/Q3 +2,083,073 15.0%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,796,231 5.9%
State Street Global Advisors Mutual Fund 2026/Q3 +1,124,512 5.7%
BlackRock Mutual Fund 2026/Q3 +782,800 8.1%
Boone Capital Management LLC Hedge Fund 2026/Q3 +704,442 1.1%
Artal Group S.A. VC/PE Fund 2026/Q3 +700,000 2.9%
RTW Investments, LP Hedge Fund 2026/Q3 +658,387 3.6%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +536,382 1.5%
Perceptive Advisors LLC VC/PE Fund 2026/Q3 +426,478 0.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
4 Nov 2026 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -195 $12.36 158,649
4 Nov 2026 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -3,805 $12.36 158,649
7 Sep 2026 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -4,000 $21.57 158,844
7 Sep 2026 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -4,000 $21.57 158,844
12 Aug 2026 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -30,000 $20.26 162,844
5 Jul 2026 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -4,000 $17.82 162,844
5 Jul 2026 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -4,000 $17.82 162,844
29 Jun 2026 Mary Fenton Chief Financial Officer Other Acquisition +1,541 $8.60 14,171
29 Jun 2026 Jacquelyn Sumer Chief Legal Officer, Chief Compliance Officer & Corporate Secretary Other Acquisition +2,470 $8.60 60,226
15 Jun 2026 Stephen Webster Independent Director Other Derivative Acquisition +25,319 $13.55 25,319
15 Jun 2026 Anthony Rosenberg Independent Chairperson Other Derivative Acquisition +25,319 $13.55 25,319
15 Jun 2026 Mary Thistle Director Other Derivative Acquisition +25,319 $13.55 25,319
15 Jun 2026 Andrew Allen Director Other Derivative Acquisition +21,781 $13.55 21,781
15 Jun 2026 David Meek Independent Director Other Derivative Acquisition +25,319 $13.55 25,319
15 Jun 2026 Mittie Doyle Director Other Derivative Acquisition +21,781 $13.55 21,781
4 May 2026 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -4,000 $15.58 166,844
4 May 2026 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -4,000 $14.60 166,844
4 Mar 2026 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -4,000 $15.68 170,844
4 Mar 2026 Jennifer Michaelson Chief Scientific Officer Derivative Exercise and Sale -4,000 $15.68 170,844
24 Feb 2026 Jennifer Michaelson Chief Scientific Officer Automatic Disposition -1,780 $14.14 174,844

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 7,928,668 12.3% 13.3
15 Oct 2026 7,640,003 11.9% 8.2
30 Sep 2026 7,634,127 11.9% 5.1
15 Sep 2026 9,629,017 15.0% 10.9
31 Aug 2026 10,371,763 16.1% 15.5
14 Aug 2026 10,588,430 16.5% 15.5

Discussion

No comments yet — be the first to weigh in on CGEM.

Sign in to join the discussion.

Scroll to Top